Category: Press Release - Page 181 - Psychedelic Alpha

Explore our new Pα+ Psychedelic Bill Tracker.

Read more about the article Pure Extracts Collaborates with Dr. Alexander MacGregor on Cannabis and Mushroom Formulations

Pure Extracts Collaborates with Dr. Alexander MacGregor on Cannabis and Mushroom Formulations

Post published:December 2, 2020
Post category:Press Release

Read more about the article Numinus and MAPS Public Benefit Corporation announce collaboration agreement to seek approval of MDMA-assisted psychotherapy for PTSD single-arm, open-label trial

Numinus and MAPS Public Benefit Corporation announce collaboration agreement to seek approval of MDMA-assisted psychotherapy for PTSD single-arm, open-label trial

Post published:December 2, 2020
Post category:Press Release

Read more about the article Havn Life Attracts International Drug Science and Policy Expert, Joins UK Policy Reform Group

Havn Life Attracts International Drug Science and Policy Expert, Joins UK Policy Reform Group

Post published:December 2, 2020
Post category:Press Release

Read more about the article Mind Cure Announces Eligibility for DTC Trading

Mind Cure Announces Eligibility for DTC Trading

Post published:December 2, 2020
Post category:Press Release

Read more about the article Mind Cure Promotes Kelsey Ramsden to President and Chief Executive Officer

Mind Cure Promotes Kelsey Ramsden to President and Chief Executive Officer

Post published:December 1, 2020
Post category:Press Release

Read more about the article CaaMTech Collaborates With the Leibniz Institute for Natural Product Research to Investigate Psychedelic Mushrooms

CaaMTech Collaborates With the Leibniz Institute for Natural Product Research to Investigate Psychedelic Mushrooms

Post published:December 1, 2020
Post category:Press Release

Read more about the article Entheon Biomedical Announces CRO Agreement with CHDR for Phase 1 Clinical Trial; Centre for Human Drug Research Led DMT Study to Start in 2021

Entheon Biomedical Announces CRO Agreement with CHDR for Phase 1 Clinical Trial; Centre for Human Drug Research Led DMT Study to Start in 2021

Post published:December 1, 2020
Post category:Press Release

Read more about the article Lobe Sciences Announces CAD$23,000,000 Sale of Cowlitz Cannabis Option to Ionic Brands Corp.

Lobe Sciences Announces CAD$23,000,000 Sale of Cowlitz Cannabis Option to Ionic Brands Corp.

Post published:December 1, 2020
Post category:Press Release

Read more about the article PharmaTher Expands Research Partnership with University Health Network For Development of Digital Therapeutics Platform

PharmaTher Expands Research Partnership with University Health Network For Development of Digital Therapeutics Platform

Post published:December 1, 2020
Post category:Press Release

Read more about the article Field Trip Health Ltd. Reports Second Fiscal Quarter 2021 Financial Results, Announces Two New Field Trip Health Center Locations

Field Trip Health Ltd. Reports Second Fiscal Quarter 2021 Financial Results, Announces Two New Field Trip Health Center Locations

Post published:November 30, 2020
Post category:Financials Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.